Reference priceEUR €4.84Original source price: INR 440.00. Converted estimates are available by currency selection.
| Brand | Skilarence |
|---|---|
| Manufacturer | ALMIRALL S.A. |
| Prescription required | Yes |
Skilarence 120mg Comprimidos,180 x 1(dimethyl fumarate)
dimethyl fumarate
Description
Skilarence 120mg Comprimidos,180 x 1(dimethyl fumarate) is a medicine catalog record in the MediPriceHub database. Active ingredient: dimethyl fumarate. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: ALMIRALL S.A.. Therapeutic category: Medicine Library > Dermatology Medicines > Drugs for psoriasis. Pack information: 120, 180. Origin country or market: Spain. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.Benefits
Dimethyl fumarate delayed-release capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.How to Use
Skilarence 30mg Skilarence 120mgSpecification
Active ingredient: dimethyl fumarate. Pack size: 120, 180. Pack unit: box. Manufacturer: ALMIRALL S.A.. Origin country: Spain. Source category: Medicine Library > Dermatology Medicines > Drugs for psoriasis. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.Side Effects
Possible adverse effects vary by active ingredient, dose, route, treatment duration, and patient condition. Common issues may include gastrointestinal symptoms, headache, dizziness, fatigue, rash, allergic reactions, or abnormal laboratory tests. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, confusion, serious bleeding, signs of infection, or rapidly worsening symptoms. The approved local prescribing information is the controlling source for the complete adverse-reaction profile.Diese Angaben dienen nur als Referenz. Lassen Sie sich vor der Anwendung eines Medikaments von medizinischem Fachpersonal beraten.